Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
Clinical trial NCT05411471 · COMPLETED
Trial details
- NCT number
- NCT05411471
- Sponsor
- Sinovac Biotech (Hong Kong) Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-08
- Primary completion
- 2023-06-25
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.